These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38135283)

  • 1. Moderating Effect of Dyspnea in the Relationship Between Death Anxiety and Self-Management in COPD: A Structural Equation Modeling Analysis.
    Aydin C; Ceyhan Y
    Omega (Westport); 2023 Dec; ():302228231224572. PubMed ID: 38135283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the feasibility to combine patients with chronic obstructive pulmonary disease and chronic heart failure in self-management groups with focus on exercise self-efficacy.
    Giezeman M; Theander K; Zakrisson AB; Sundh J; Hasselgren M
    Scand J Prim Health Care; 2022 Jun; 40(2):208-216. PubMed ID: 35575429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.
    Lee JS; Seo JB; Lee SM; Park TS; Lee SW; Oh YM; Lee JH; Kim EK; Kim TH; Park JH; Sheen SS; Lim SY; Jung I; Lee SD
    J Thorac Dis; 2015 Oct; 7(10):1765-73. PubMed ID: 26623099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Modified Medical Research Council Dyspnea Scale for Predicting Hospitalization and Exacerbation in Japanese Patients with Chronic Obstructive Pulmonary Disease.
    Natori H; Kawayama T; Suetomo M; Kinoshita T; Matsuoka M; Matsunaga K; Okamoto M; Hoshino T
    Intern Med; 2016; 55(1):15-24. PubMed ID: 26726080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
    Pandey AK; Verma AK; Singh A; Kant S; Dixit RK; Chaudhary SC; Bajpai J; Prakash V; Verma UP
    Cureus; 2022 Dec; 14(12):e32116. PubMed ID: 36601200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Karayama M; Mori K; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Respir Med; 2019 Jan; 146():76-80. PubMed ID: 30665522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between pulmonary quantitative CT measurement indicators and respiratory symptoms in patients with chronic obstructive pulmonary disease in stable stage].
    Wang YX; Sun TY; Li YM; Zhang M; Wang GX; Chen QH; Guo YF
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(38):3017-3025. PubMed ID: 37813652
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CHRONIC PANCREATITIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CLINICAL ASPECTS OF COMORBIDITY].
    Zhelezniakova NM; Pasiiyeshvili TM
    Eksp Klin Gastroenterol; 2016; (6):28-32. PubMed ID: 30280548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, Charlson comorbidity index, and neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: relationship to disease severity.
    Uzunlar EA; Yildiran H; Kokturk N; Kilic H; Hasanoglu HC
    Bratisl Lek Listy; 2023; 124(7):520-526. PubMed ID: 37218479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between fear of movement, pain and fatigue severity, dyspnea level and comorbidities in patients with chronic obstructive pulmonary disease.
    Vardar-Yagli N; Calik-Kutukcu E; Saglam M; Inal-Ince D; Arikan H; Coplu L
    Disabil Rehabil; 2019 Sep; 41(18):2159-2163. PubMed ID: 29631469
    [No Abstract]   [Full Text] [Related]  

  • 16. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inspiratory muscle training on dyspnea-related kinesiophobia in chronic obstructive pulmonary disease: A randomized controlled trial.
    Saka S; Gurses HN; Bayram M
    Complement Ther Clin Pract; 2021 Aug; 44():101418. PubMed ID: 34034036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients.
    Pisi R; Aiello M; Calzetta L; Frizzelli A; Tzani P; Bertorelli G; Chetta A
    Pulmonology; 2023; 29(3):194-199. PubMed ID: 34233862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
    Ammous O; Feki W; Lotfi T; Khamis AM; Gosselink R; Rebai A; Kammoun S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013778. PubMed ID: 36606682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.